Article
The Forteo Patient Registry linkage to multiple state cancer registries: study design and results from the first 8 years
5 Jul 2018
Abstract excerpt
The Forteo Patient Registry (FPR) aims to estimate the incidence of osteosarcoma in US patients treated with teriparatide. Enrollment began in 2009 and will continue through 2019, with linkage planned through 2024. To date, no incident cases of osteosarcoma have been identified among patients registered in the FPR. INTRODUCTION: The Forteo Patient Registry (FPR) was established in 2009 to estimate the incidence...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
